
ED Officials Reach Tihar Jail, Arrests Former Fortis Promoter Shivinder Singh
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins

Officials said an Enforcement Directorate (ED) team reached the Tihar jail here in the evening and placed former Fortis promoter Shivinder Singh under arrest as per provisions of the Prevention of Money Laundering Act (PMLA).
New Delhi: The ED on Thursday arrested former Fortis Healthcare promoter Shivinder Singh in a money laundering case related to alleged misappropriation of funds at Religare Finvest Ltd (RFL), officials said.
They said an Enforcement Directorate (ED) team reached the Tihar jail here in the evening and placed Shivinder Singh under arrest as per provisions of the Prevention of Money Laundering Act (PMLA).
Shivinder Singh was in judicial custody after the Delhi Police's Economic Offences Wing (EOW) had arrested him and others recently.
Also Read: Need further Custodial interrogation of former Fortis Healthcare promoter Malvinder Singh: ED tells Court
On Thursday, a Delhi Court had rejected his bail plea in the police case. He will be produced before a special PMLA court here on Friday with a plea to obtain his custody, the officials said.
Shivinder Singh's brother Malvinder (46), also a former Fortis Healthcare promoter, former CMD of Religare Enterprises Ltd (REL) Sunil Godhwani (58), Kavi Arora (48) and Anil Saxena were arrested by the EOW for allegedly diverting RFL's money and investing in other companies.
Malvinder and Godhwani were arrested earlier by the ED in this money laundering case.
The ED had told the court that both the brothers along with others had transferred an amount of about Rs 1,000 crore to various persons from entities linked to the corporate loan book and finally, the money was siphoned off and laundered.
RFL is a group firm of REL that was earlier promoted by the Singh brothers (Malivinder Mohan Singh and Shivinder Mohan Singh).
Read Also: Singh brothers, 3 others arrested for massive Rs 2400 crore fund misappropriation in Religare
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:

Recent News
Normal-Tension Glaucoma Closely Associated With Co...
- 10 October, 2022
Air Pollution Tied To Increased Risk Of Premature...
- 24 May, 2023
NEET PG 2024: NBE Opens Pre-Final Edit Window
- 30 May, 2024
NMC Mulls Over Removal Of Upper Age Cap In MBBS En...
- 30 November, 2021

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!